APA (7th ed.) Citation

Eckardt, J., Stasik, S., Röllig, C., Petzold, A., Sauer, T., Scholl, S., . . . Thiede, C. (2023). Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia, 37(12), . https://doi.org/10.1038/s41375-023-02061-1

Chicago Style (17th ed.) Citation

Eckardt, Jan-Niklas, et al. "Mutated IKZF1 Is an Independent Marker of Adverse Risk in Acute Myeloid Leukemia." Leukemia 37, no. 12 (2023). https://doi.org/10.1038/s41375-023-02061-1.

MLA (9th ed.) Citation

Eckardt, Jan-Niklas, et al. "Mutated IKZF1 Is an Independent Marker of Adverse Risk in Acute Myeloid Leukemia." Leukemia, vol. 37, no. 12, 2023, https://doi.org/10.1038/s41375-023-02061-1.